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is TB Testing associated With 
increased Blood interferon-gamma 
levels?
Aideen E. Kennedy1,2, Jim O’Mahony 2, Noel Byrne1, John MacSharry3  
and Riona G. Sayers1*
1Animal and Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Fermoy, 
Ireland, 2 Department of Biological Sciences, Cork Institute of Technology, Cork, Ireland, 3 Alimentary Pharmabiotic Centre, 
Biosciences Institute, University College Cork, Cork, Ireland
The Republic of Ireland reports a relatively low prevalence of Johne’s disease (JD) 
compared to international counterparts. Postulated reasons for this include a lower 
average herd size and a grass-based production system. Ireland also engages in high 
levels of bovine tuberculosis (bTB) testing. As interferon-gamma (IFN-γ) is believed to 
play a key role in protecting against JD, it is our hypothesis that administration of purified 
protein derivative (PPD), as part of the bTB test, is associated with a systemic increase 
in IFN-γ production, which may potentially limit clinical progression of the disease. 
We studied 265 cows (202 Friesian and 63 “Non-Friesian,” e.g., JerseyX, Norwegian Red) 
to assess IFN-γ levels and Mycobacterium avium subspecies paratuberculosis (MAP) 
antibody response before and after the bTB test. As part of the compulsory annual bTB 
test, avian and bovine PPD were administered at two separate cervical sites. To assess 
IFN-γ production, blood samples were taken before and 72 h after PPD administration. 
MAP antibody response was assessed before and 10 days post-PPD administration. 
A significant increase in MAP antibody response was identified post-bTB compared to 
pre-bTB response (p < 0.001). Additionally, IFN-γ production significantly increased at 
the post-bTB time point (p < 0.001) compared to the pre-bTB test readings. This may 
indicate a beneficial effect of bTB testing in controlling JD.
Keywords: Johne’s disease, TB test, interferon-gamma, purified protein derivative, elisa
inTrODUcTiOn
Mycobacteria are a leading cause of debilitating infections in domesticated animals and wildlife (1). 
Certain mycobacteria also have public health implications, such as bovine tuberculosis (bTB). 
Compulsory eradication schemes were initiated in the Republic of Ireland in the 1960s to both 
protect human health and agricultural exports (2). Although levels of TB in the human population 
in Ireland have dramatically reduced in the past 50 years, bTB eradication remains necessary in order 
to comply with European trading conditions (Directive 64/432 EEC) (2).
Bovine tuberculosis is caused by Mycobacterium bovis (M. bovis). In the late 1800s, Robert Koch 
identified the tubercle bacillus and also developed tuberculin, a glycerol extract of pure culture of 
tubercle bacilli (3). The intradermal skin test has been used diagnostically for detection of human 
and bovine TB for over 100 years. Originally performed using Koch’s Old tuberculin, a more stable 
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and consistent preparation known as purified protein derivative 
(PPD), is now used for intradermal tests. PPD is produced by 
growing a mycobacterial organism on liquid culture, subse-
quently heat treating, filtering, washing, and then re-dissolving 
into a sterile preparation free from intact mycobacteria (4, 5). 
When injected intradermally, PPD provides an antigen source 
to identify animals whose immune system has been sensitized 
by previous exposure to the mycobacterium. Sensitization in an 
animal is identified by development of an edematous lesion at the 
site of injection.
Antemortem screening for bTB in Ireland is conducted 
using the single intradermal cervical comparative test (SICCT). 
All bovines over 6 weeks of age are tested a minimum of once 
per year. Good et al. (6), on analyzing results from 1,703 herds 
restricted with bTB, found over 18% of animals (10,962) received 
two tests with a small number of animals (7) tested five times in 
a single year. While many countries use the single intradermal 
test, where M. bovis PPD is administered in isolation, the SICCT 
utilizes intradermal introduction of both M. bovis (bPPD) and 
M. avium (aPPD) PPD at two different sites on the neck (5). 
A relative difference in the size of the edematous lesion of >4 mm 
at the bPPD injection site compared to aPDD site indicates a posi-
tive result (4).
Interferon gamma (IFN-γ) is an inflammatory cytokine that 
is critical to both innate and adaptive immune systems (7) across 
mammalian species. It is an important activator of macrophages 
following bacterial exposure (8). IFN-γ in more recent decades 
has been applied as a tool in the diagnosis of mycobacterial dis-
eases such as bTB and human tuberculosis (5, 9), Johne’s disease 
(JD) (10), and leprosy (11).
The interferon-gamma assay is approved by the EU for bTB 
testing (5) and is used as an ancillary test in the Irish bTB eradica-
tion scheme. The IFN-γ test involves incubation of heparinized 
blood samples in the presence of test antigens (avian and bovine 
PPD). Subsequently, plasma supernatant from each blood aliquot 
is harvested. IFN-γ production is estimated using an enzyme 
immunoassay (EIA) (12). IFN-γ testing can either be used to 
confirm bTB SICCT positive reactors or alongside intradermal 
tests to increase diagnostic sensitivity (13).
Purified protein derivative administration has been shown 
to boost in vitro IFN-γ production in the case of bTB (14, 15). 
Ota et  al. (16) found skin testing alone significantly induced 
PPD-specific IFN-γ producing cells in humans. Furthermore 
Thom et  al. (17) conducted a study to determine the effect of 
repeated skin testing on immune responses of calves following 
experimental infection with M. bovis. Prior to experimental 
infection, during an undefined transient infection (as evidence by 
an IL10 response), the authors noticed that, compared to calves 
that received multiple skin tests, control animals appeared to have 
higher proliferative responses and IFN-γ synthesis. The authors 
proposed that multiple skin tests had either led to a suppressed 
response to the transient infection or alternatively that skin test-
ing had aided protection against this transient infection, thus 
highlighting important interactions between PPD administration 
and host immune responses.
An additional pathogenic and speculated zoonotic member 
of the Mycobacteriaceae is Mycobacterium avium subspecies 
paratuberculosis (MAP), the causative agent of JD in cattle (18). 
Currently, there is no effective treatment for JD, and control is 
based on breaking the cycle of transmission to susceptible ani-
mals by limiting contact with MAP-infected feces, colostrums, 
and milk (19). It is generally believed that early subclinical MAP 
infections result in a cell-mediated immune response involv-
ing delayed type hypersensitivity (DTH) with production of 
cytokines by T-lymphocytes, including IFN-γ (20, 21). Indeed, 
IFN-γ has been established as an important cytokine in host 
defenses against JD (21).
Ireland reports a relatively low prevalence of MAP sero-
positivity (22). Additionally, Kennedy et  al. (23) have hypoth-
esized that Irish cows may be less susceptible than international 
counterparts to developing clinical signs (progressive emaciation 
and diarrhea) of JD. Reasons suggested for this include low 
average herd size (75 cows), a predominantly grass-based diet, 
and the comprehensive bTB testing regime conducted in Ireland 
(23, 24). In terms of investigating this further, we sought to exam-
ine the impact of administration of avian and bovine PPD, as part 
of the required annual SICCT test, on in  vivo levels of plasma 
IFN-γ. Our overall objective was to elucidate whether bTB testing 
in Ireland could be contributing to MAP control/suppression in 
Irish herds.
MaTerials anD MeThODs
study cows
A total of 265 cows were recruited to the study in April 2016 from 
a farm that had been depopulated in 1997 following confirma-
tion of a case of BSE. The current herd, therefore, consisted of 
descendants of cows used to repopulate the farm (25). Since 
establishment of the new herd in 2000, cows from 47 different 
herds of origin had been purchased into the herd. Breed, age, par-
ity, MAP ELISA status, and bTB status was available for each cow. 
Approximately 85% of the herd were spring-calving (i.e., calving 
between 1st January and 30th April). Herd SICCT history was 
examined in advance of recruitment of the herd to the study 
and revealed minimal issues with bTB (no reactors in 5 years). 
All, bar eight animals in the current study, were from the same 
herd of origin and, therefore, were subjected to similar frequency 
of annual SICCT. All animals had previously partaken in a mini-
mum of two SICCTs. The herd had been enrolled in the voluntary 
Animal Health Ireland (AHI) pilot JD control programme since 
2014. All animals were examined for clinical signs of JD prior 
to study initiation. Although the study herd contained six MAP 
ELISA positive animals, no animal displayed clinical signs of JD.
single intradermal cervical  
comparative Test
The routine annual SICCT was administered by the farm’s private 
veterinary practitioner in May 2016. It was conducted in line with 
standard Department of Agriculture guidelines (26). Briefly, on 
the middle one third of the neck, two injection sites (dorsal and 
ventral), 12.5 cm apart, were clipped and skin-thickness meas-
urements recorded with calipers. McLintock syringes (Duggan 
Veterinary, Ireland) were used to administer 0.1 mL avian PPD 
3Kennedy et al. TB Testing and JD
Frontiers in Veterinary Science | www.frontiersin.org October 2017 | Volume 4 | Article 176
dorsally and 0.1 mL of bovine PPD at the ventral site. PPD was 
supplied by DAFM in line with statutory requirements. Seventy-
two hours post-PPD administration skin thickness measurements 
at both injection sites were re-assessed to evaluate the presence or 
absence of a DTH response.
Blood samples
Blood samples were collected pre- and 72  h post-PPD admin-
istration. Pre-SICCT samples were tested for both IFN-γ and 
MAP serological response. The 72-h post samples were tested 
for IFN-γ levels only. This time-point was chosen as Coad et al. 
(27), reported a statistically significant increase in in vitro IFN-γ 
response 3 days post-bPPD administration. Based on results by 
Kennedy et al. (24) and Kennedy et al. (23) indicating increased 
production of MAP antibodies post-PPD administration, a 
blood sample was collected ten days post-SICCT to examine the 
serological response on MAP ELISA. The sampling protocol was 
approved by the Teagasc Animal Ethics committee and a study 
license was granted by the Irish Health Products Regulatory 
Authority (HPRA). Blood samples were taken from the coccy-
geal vein using 20-Gauge needles into evacuated lithium heparin 
blood sampling tubes. Samples were centrifuged for 15  min at 
3,000 g and plasma aspirated for same-day testing.
MaP elisa
Mycobacterium avium subspecies paratuberculosis ELISA tests 
were conducted by a commercial ISO17025 accredited labora-
tory (Enfer Kildare), designated by AHI for the Irish voluntary 
JD control programme. Samples were tested using the ID Screen 
Paratuberculosis Indirect Screening Test (ID Vet, Montpellier, 
France). Results were reported as sample to positive ratios (S/P 
ratio) calculated using the formula S/P ratio = [(OD Sample − OD 
Negative control) ÷  (OD Positive control −  OD Negative con-
trol) × 100]. The test is an M. phlei absorbed ELISA, which detects 
anti-MAP IgG. For the purposes of reporting within-herd MAP 
prevalence, ELISA S/P ratio results were categorized according 
to manufacture instructions, i.e., samples recording S/P ratios of 
≥70 S/P categorized as seropositive.
iFn-γ sample Preparation and Testing
Samples for IFN-γ were tested using a modified version of Bovigam 
IFN-γ kit (Celtic Diagnostics Ltd., Dublin 22, Ireland). The first 
step in this test typically involves a blood culturing step, involv-
ing addition of a negative control antigen, avian PPD, and bovine 
PPD to three separate aliquots of whole blood and incubated 
overnight. The second stage comprises measuring the production 
of IFN-γ (absorbance value) from the stimulated lymphocytes in 
separated plasma using a monoclonal antibody-based sandwich 
EIA. For our purposes, we used the intradermal administration 
of PPD to study cows as the lymphocyte stimulation step, and 
following centrifugation, assayed plasma directly using the IFN-γ 
EIA. This was deemed a suitable methodology as our purpose was 
to compare in vivo IFN-γ levels pre- and post-PPD administration 
as opposed to identifying bTB infected cattle. All plasma samples 
for IFN-γ were plated within 6 h of blood collection from cows.
Samples were assayed in duplicate and results reported as 
optical density values at 450  nm (OD450). The conventional kit 
interpretation is calculated by comparing mean negative control 
antigen, avian PPD, and bovine PPD OD450 values. In the current 
study, we simply compared mean pre- and post-SICCT plasma 
IFN-γ levels as all cows were required to be administered with both 
avian PPD and bovine PPD. It should be noted that two ELISA 
plates recorded negative controls outside manufacturer recom-
mendations (Recommended Mean Negative Control < 0.13. The 
two plates recorded negative controls of 0.15 and 0.186, respec-
tively). As the kit was not being used as conventionally specified, 
it was decided to perform analysis including and excluding results 
from both plates (n =  264 vs. n =  179 cows). Analysis yielded 
broadly similar results, analysis relating to breed differences, 
however, changed to recording a tendency (p =  0.088) rather 
than statistical significance (p = 0.04). Results reported are from 
n = 264 cows. In the interest of completeness, values (maximum, 
median etc.) from n =  179 cows are provided throughout the 
manuscript and labeled “analysis 179 cows.” Additionally, figures 
and tables from “analysis 179 cows” are provided as supplemen-
tary files.
cow classification
For SICCT, all cows were classified based on relative differences in 
skin thickness measurements at avian and bovine PDD injection 
sites. An animal displaying a >4 mm skin thickness increase at 
bovine compared to avian injection sites was classified as a positive 
reactor, an increase of >2–4 mm as an inconclusive, and animals 
with lower or no increases in skin thickness measurements classi-
fied as negatives. In terms of MAP ELISA, manufacturer positive 
cut-off values were applied to classify cows as seropositive or 
seronegative. Cows were also classified on the basis of breed 
(Holstein-Friesian, non-Holstein-Friesian) and parity (1–8).
Data analysis
Descriptive analysis and dataset construction were completed 
in Excel (MS Office 2010). Figures were constructed using Excel 
(MS Office 2010) and GraphPad Prism. Normality of continuous 
datasets was examined visually using ladders of power histo-
grams. Statistical analyses were completed using Stata version 
12 (StataCORP, USA). Wilcoxon rank sum tests were used to 
investigate differences between pre- and post-SICCT IFN-γ 
OD450 results, pre- and post-SICCT MAP ELISA results, avian 
PPD site measurements, and bovine PPD site measurements 
(continuous variables). Univariable linear regression was initially 
used to examine the association between IFN-γ production 
(dependent variable) and sampling time point (pre-SICCT vs. 
post-SICCT), breed (Friesian vs. non-Friesian), parity (1, 2, 3, 4, 
5, 6, 7, 8), changes in skin thickness measurement due to DTH 
pre- and post-avian PPD administration (continuous variable 
in millimeter) and skin thickness measurement due to DTH 
pre- and post-bovine PPD administration (continuous variable 
in millimeter). Difference between pre and post-SICCT MAP 
ELISA S/P ratio was also examined as an independent variable. 
A multivariable generalized estimating equation (GEE) was 
subsequently built using independent variables, which yielded 
p-values ≤0.10 (Table 1) in univariable models.
A second GEE analysis was conducted to investigate associa-
tions between MAP ELISA S/P ratio (dependent variable) and 
TaBle 1 | Univariable analysis examining associations between variables.
Breed Parity Pre-single 
intradermal 
cervical 
comparative test 
(siccT) iFn
Post-
siccT 
iFn
Pre-siccT 
Mycobacterium 
avium subspecies 
paratuberculosis 
(MaP)
Post-
siccT 
Map
avian 
response
Bovine 
response
Difference 
iFn pre/
post 
siccT
Parity 0.77
Pre-SICCT IFN 0.76 0.23
Post-SICCT IFN 0.041 0.84 0.63
Pre-SICCT MAP 0.41 0.02 0.12 0.31
Post-SICCT Map 0.21 0.96 0.05 0.77 <0.001
Avian response (mm) 0.81 0.69 0.31 0.8 0.04 <0.001
Bovine response (mm) 0.58 0.39 0.28 0.08 0.04 <0.001 <0.001
Difference IFN Pre/post SICCT 0.06 0.64 <0.001 <0.001 0.53 0.88 0.63 0.05
Difference MAP response Pre/post 
SICCT
0.29 0.39 0.06 0.89 0.12 <0.001 <0.001 <0.001 0.58
p-Values in bold highlight variables subsequently included in logistic regression models.
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the independent variables described previously, namely, sampling 
time point, breed, parity, and skin thickness measurements at 
avian and bovine PPD injection sites. Difference between pre 
and post-SICCT IFN-γ production was also examined as an 
independent variable. GEE models were constructed by back-
wards elimination with a forward step. Second level interactions 
between independent variables were examined and included in 
both models at p ≤ 0.05. A Gaussian distribution and an identity 
link function were used.
resUlTs
herd information
The study herd consisted of 202 Friesians or Friesian crosses and 
the remainder were predominantly Jersey or Jersey crosses and 
a small number of Norwegian red (21) (Analysis 179 cows: 138 
Friesians, 26 Jersey, 15 Norwegian red).
single intradermal cervical comparative Test
A total of two animals were classified as inconclusive on SICCT 
but none were classified as bTB positive (inconclusive 1: skin 
measurements at bPPD site increased from 7 to 10  mm, no 
increase in skin thickness was recorded at aPPD. The second 
inconclusive animal recorded an increase of 7 mm at the bPPD 
site and 3 mm at the aPPD site: Both inconclusive animals were 
subjected to repeat SICCT at a 60-day interval and tested bTB 
negative). In all, 91 animals exhibited DTH to aPPD and the 
maximum increase in skin thickness recorded at the avian PPD 
site post-SICCT was 11 mm (range 0–11 mm, median 0 mm). 
With regard to bovine PDD, 36 animals recorded DTH against it 
(range 0–7 mm, median 0 mm), 35 of whom had also recorded 
avian PPD DTH [analysis 179 cows: 61 animals exhibited DTH 
to aPPD (range 0–11 mm, median 0 mm), 20 animals recorded 
DTH to bovine PDD (range 0–4 mm, median 0 mm), 19 of whom 
had also recorded avian PPD DTH].
iFn-γ Plasma Detection
The pre-SICCT IFN-γ OD450 ranged from 0.001 to 0.08 (median 
0.02) [analysis 179 cows: 0.001 to 0.08 (median 0.02)]. Post-SICCT 
IFN-γ measurements ranged from 0.001 to 0.507 (median: 0.05) 
(Figure 1) [analysis 179 cows: range 0.001–0.507 (median: 0.03)]. 
A single cow recorded a pre-SICCT IFN-γ measurement of 0.7405 
and was, therefore, removed from the analysis as an outlier; this 
animal showed no increase in skin thickness at either the aPPD or 
bPPD injection site and post-PPD IFN-γ response was in line with 
the remainder of the herd (0.25). Statistically, post-SICCT IFN-γ 
measurements were significantly higher than pre-SICCT OD450 
values (p < 0.001) (analysis 179 cows: p < 0.001). Similarly, the 
multivariable GEE analysis highlighted a statistically significant 
increase in IFN-γ production post-SICCT (Table 2). It should be 
noted, however, that 62 animals recorded either no change or a 
decrease in IFN-γ response. A lower increase in IFN-γ production 
post-SICCT was recorded in non-Holstein-Friesian compared to 
Holstein-Friesian cows (p = 0.04) (Table 2) (analysis 179 cows: 
p = 0.088).
MaP elisa
Prior to the administration of avian and bovine PPD, six animals 
were classified as MAP ELISA positive with S/P ratios ranging 
from 72 to 189 (median = 97.1). Post-SICCT, 64 animals were 
classified as MAP ELISA positive, values ranged from 70 to 229 
with a median S/P ratio of 112.6 [analysis 179 cows: pre-SICCT 
four animals were classified as MAP ELISA positive with S/P 
ratios ranging from 75.7 to 189 (median = 113.89). Post-SICCT, 
43 animals were classified as MAP ELISA positive, values ranged 
from 75 to 229 with a median S/P ratio of 112].
A significant increase in MAP serological response was iden-
tified post-SICCT compared to pre-SICCT response (p < 0.001) 
(Figure 2) (Analysis 179 cows: p < 0.001). A significant associa-
tion was identified between MAP S/P ratio and both avian and 
bovine PPD DTH response. For every 1 mm increase in bovine 
PPD DTH, an increase in MAP S/P ratio of 4.4 was identified 
(p = 0.013). Similarly for every 1 mm increase in avian DTH, 
an increase in MAP S/P ratio of 3.4 was recorded (p < 0.001) 
(Table  3). Univariable linear regression identified no asso-
ciation between post-SICCT IFN-γ and antibody production. 
A scatter plot in Figure 2 shows the relationship between each 
variable.
TaBle 2 | Significant associations between interferon-gamma (IFN-γ) production 
and independent variables (n = 264).
Dependent variable coefficient p-Value 95% conf. 
interval
Model (model 
p-Value)
independent variable
iFn-γ production
Post-single intradermal 
cervical comparative test 
(SICCT) vs. pre-SICCT
0.05 <0.001 0.04, 0.06 testing time 
point, breed, 
(p: < 0.001)
Non-Friesian vs. Friesians −0.01 0.04 −0.02, 
−0.001
FigUre 1 | (a) Shows individual interferon-gamma (IFN-γ) and Mycobacterium avium subspecies paratuberculosis (MAP) value recorded for each cow both pre and 
post-single intradermal cervical comparative test (SICCT). (B) Shows Spear style box plots of IFN-γ and MAP ELISA response both pre- and post-SICCT (n = 264). 
Wilcoxon rank sum identified significant differences between pre- and post-SICCT IFN-γ OD450 results and pre- and post-SICCT MAP ELISA results.
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DiscUssiOn
The primary aim of this study was to investigate if the admin-
istration of PPD during the routine annual SICCT for bTB was 
associated with an increase in circulating plasma IFN-γ. The 
significant association highlighted between PPD administration 
and an increase in systemic IFN-γ provides support for the theory 
that SICCT may have a potential immuno-protective influence in 
Irish cattle with regard to MAP infections and may contribute to 
the relatively low levels of overt clinical signs of JD experienced 
on Irish farms (24).
Interferon-gamma, originally called macrophage-activating 
factor (28), orchestrates a diverse array of cellular activities, 
including upregulation of pathogen recognition, antigen process-
ing, and antigen presentation. During infection, IFN-γ-induced 
actions result in heightened immune system function and 
surveillance, with IFN-γ amplifying immune system response 
to pathogens (28). IFN-γ has been established as an important 
cytokine in defenses against mycobacterial disease (21, 29, 30) and 
appears important in limiting infection by MAP (31). In human 
medicine, IFN-γ has been used as a therapeutic adjuvant in wide 
range of diseases from atopic dermatitis (32) to ovarian cancer 
(33). Marciano et al. (34) found that prophylactic use of IFN-γ 
was effective in patients with chronic granulomatous disease. 
Given the role of IFN-γ in limiting progression of MAP infections 
(31) and its use as a therapeutic adjuvant and prophylactic agent, 
the increased level of IFN-γ recorded post-PPD administration in 
the current study may indicate TB-testing can contribute to MAP 
control in Irish dairy cows. As some animals in Ireland face up to 
five tests in 1 year (6), the suggested protective effect of TB-testing 
may help limit progression of MAP infections.
Conflicting reports exist in the literature relating to PPD 
administration stimulating increased production of IFN-γ 
in vitro. Indeed, in the current study, 62 animals did not record 
an increase in IFN-γ. Many studies report no significant effect 
observed after PPD administration (27, 35, 36), while others 
(14, 15) found increased IFN-γ responses. On reviewing relevant 
literature, Schiller et al. (37) found it could not be disregarded 
that skin testing induces an IFN response particularly in animals 
sensitized to environmental mycobacteria. It has been reported 
by Buddle et al. (38) that many animals are naturally sensitized 
to environmental mycobacteria at a young age and develop an 
immunological response to such antigens by 6  weeks of age. 
TaBle 3 | Significant associations between Mycobacterium avium subspecies 
paratuberculosis (MAP) ELISA response and independent variables (n = 264).
Dependent 
variable
coefficient p-Value 95% conf. 
interval
Model (model 
p-Value)
independent 
variable
MaP elisa 
response
Post-SICCT vs. 
pre-SICCT
33.9 <0.001 28.5, 39.4 Testing time point, 
Avian purified 
protein derivative 
(PPD) delayed type 
hypersensitivity (DTH) 
response, Bovine 
PPD DTH response 
(p-Value: <0.001)
Avian PPD DTH 
response (mm)
3.4 <0.001 1.7, 5.0
Bovine PPD DTH 
response (mm)
4.4 0.013 0.1, 7.9
FigUre 2 | Scatter plot showing the relationship between post SICCT interferon-gamma (IFN-γ) and MAP ELISA antibody response (n = 264). IFN-γ × 1,000 to aid 
visualization.
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Ireland is recognized as having an abundance of environmental 
mycobacteria (39). As Irish livestock systems are largely grass-
based with animals only housed for 2–3 months per year, poten-
tial exposure to such mycobacteria is probable. It is possible; 
therefore, that prior infection with environmental mycobacteria 
is contributing to the significant increase in the IFN-γ response 
post-SICCT recorded in our study. Hope et al. (40) also reported 
prior exposure to M. avium induces low level protection to 
M. bovis and may prime host immune responses. As to whether 
this could be extrapolated to environmental mycobacteria induc-
ing low level protection against MAP in Irish cattle requires 
further investigation, but deserves serious consideration.
Vaccines have been available for JD since the early 20th cen-
tury. The majority of vaccines are based on killed mycobacterium 
cells in an oil-based adjuvant. Use is prohibited in a number of 
countries due to interference with TB diagnostics (41). If results 
in the current study could be expanded upon and it was shown 
that PPD was exerting a vaccine-like effect, it may highlight a new 
control approach for areas not currently engaging in bTB testing 
programmes to a similar extent as Ireland. Although, not perfect 
as clinical JD, does occur in Ireland, few vaccines will report 100% 
efficacy (41). Research is required to see if a modified PPD prepa-
ration and administration protocol could provide a comparable 
response to disease as provided by commercial vaccines.
An interesting finding from this study is that non-Holstein-
Friesian breeds, consisting predominantly of Jersey and Jersey 
cross cows, produced less IFN-γ in the post-PPD period than 
Holstein-Friesian and crosses. A number of studies have 
reported an increased likelihood of Channel Island breeds testing 
MAP positive (42–44). Verschoor et  al. (45) reported differing 
expression of genes related to immune response and antigen 
processing in MAP infected Friesians versus Jerseys. Ballou (46) 
demonstrated reduced immune responses to E-coli infection in 
Jersey calves compared to Holstein-Friesians. More specifically, 
of four MAP fecal culture positive animals detected in a single 
Irish mixed-breed herd over a 5-year period, all were of Jersey 
ancestry (Kennedy et al., unpublished data). It is possible, there-
fore, that Channel Island cow breeds have a lesser ability to mount 
an immune response effective at clearing MAP infection. Indeed, 
genomic variation within the IFN-γ gene may account for differ-
ences between breeds (47). From a purely practical point of view, 
potentially more stringent MAP-related management practices 
should be considered in herds containing Channel Island breeds 
to minimize JD transmission. Such an approach could also include 
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a more severe interpretation of ELISA results during MAP herd 
surveillance. As the heritability of MAP susceptibility in Jersey 
cows has been reported at between 8 and 27% (48), an appropriate 
breeding programme could also greatly assist in improving MAP 
outcomes in Jersey cows.
In agreement with previous studies (24, 49), administration of 
PPD was associated with an increase in MAP antibody response. 
The current study only examined the response at day 10 post-PPD 
administration, but previous research on Irish dairy herds (24) has 
recommended avoiding testing for MAP antibodies until day 71 
post PPD to avoid potential interference with MAP ELISA results. 
An association was likewise identified in this study between DTH 
skin reactions and MAP ELISA antibody response in agreement 
with a previous study (50). In that study, it couldn’t be determined 
whether increases in post-PPD MAP antibody responses were 
due to increased sensitivity at detecting MAP-infected animals, 
or as a result of decreased specificity due to cross reacting anti-
bodies. Interestingly, Hostetter et al. (51) reported that given the 
appropriate environment, opsonization of MAP with specific 
antibodies can lead to an oxidative burst and reduced survival 
of MAP. In the study by Hostetter et al. (51), MAP bacteria were 
opsonized for 24 h with serum from animals confirmed positive 
for MAP antibodies. According to Kennedy et al. (24), a statisti-
cally significant increase in MAP antibody response persists 
until 71 days post-PPD administration, indicating the post-PPD 
increase in MAP antibody response would exist for a sufficient 
time to allow opsonization of bacteria to occur. Potentially, this 
may indicate that MAP antibodies produced post the administra-
tion of SICCT, may contribute to the control of MAP. Further 
research would be required, however, as other researchers have 
reported the ineffectiveness of antibodies in controlling MAP.
Although formal comparison of MAP prevalence across 
studies is difficult due to variation in study design (52), the herd 
prevalence reported in Ireland (21.4% of herds reporting at least 
one ELISA positive) (22) is relatively low, compared to a number 
of international counterparts. A review of MAP prevalence across 
Europe reported a between herd prevalence “guesstimate” of 
>50% (52). Different bTB testing regimes operate internation-
ally. Many countries do not implement a minimum of a once 
annual SICCT as occurs in Ireland. In the majority of European 
countries that engage in bTB testing, bovine PPD is applied to 
the cervical region (cervical single intradermal test; SIT) (53). 
Indeed, a number of European countries are officially bTB 
free and don’t conduct routine testing for bTB, including the 
Netherlands (54), who report a MAP prevalence of between 31 
and 71% (55). Elsewhere, in North America and the Southern 
Hemisphere, bovine PPD is applied via the caudal fold test. In 
these regions, MAP prevalence also appears greater than Ireland. 
A herd level apparent prevalence of 70.4% was reported in US 
dairy herds by Lombard et al. (56). Vilar et al. (57) have reported 
prevalence’s of 26.6–41.4% in certain regions of Brazil. In Ireland 
and the UK, poor specificity is reported for the SIT; therefore, 
the SICCT is used to test for bTB (53). Although the SICCT 
is used in both countries, differences exist in the frequency of 
bTB testing. Within the UK testing intervals of up to 4 years are 
permitted in certain regions. Perhaps, the reduced frequency of 
bTB testing conducted in the UK compared to Ireland accounts 
for the increased prevalence of MAP reported in the UK [68% 
reported by Velasova et al. (58)]. It would be interesting to study 
whether areas engaging in bTB testing every 4 years report higher 
MAP prevalence compared to those areas within the UK testing 
annually.
It should be noted that the relatively low prevalence of 
MAP in Irish herds may be attributable to a number of other 
factors. Previously suggested reasons include outdoor grazing 
systems and a lower average herd size compared to international 
counterparts (23). It has also previously been suggested that TB 
testing may contribute to JD control, as MAP-infected animals 
can show false positive reactions to SICCT and be removed from 
the herd. This study is the first of our knowledge to hypothesize 
if TB-testing may contribute to MAP control in Ireland and 
investigate if PPD can induce production of cytokines known to 
be immunologically important in the control of JD. Results are 
suggestive, however, that bTB-testing may be contributing to JD 
control and requires comprehensive investigation. This current 
study, however, involves a single herd only at one bTB test only 
and more comprehensive studies are required to further inves-
tigate our hypothesis. In addition to inclusion of an increased 
number of herds, future work should also examine T-cell subsets 
and include investigation of mRNA expression levels. Examining 
the length of time, the IFN-γ response persists would also be 
valuable. Equally Stabel et  al. (59), when examining IFN-γ 
response post intradermal stimulation with johnin found greater 
IFN-γ production in subclinically infected animals compared to 
control and clinically infected animals. Therefore, in future stud-
ies, it would be interesting to include herds with both clinically 
and subclinically infected cows and examine their respective 
post-PPD IFN-γ responses.
Although representing different arms of the immune response, 
the association between post-SICCT IFN-γ and antibody produc-
tion was examined. While there was an increase in both post-SICCT 
IFN-γ and antibody production, no association was highlighted 
between them. As Mikkelsen et al. (60) reports that cell-mediated 
responses can control or eradicate MAP, it may indicate that the 
animals with increased IFN-γ production in the current study 
are limiting the progression of the disease, and not producing 
significant IgG antibody levels. Indeed, studies demonstrate 
that IFN-γ enhances macrophage autophagy function (61). The 
increased plasma IFN-γ levels may suggest enhanced macrophage 
autophagy and clearance of mycobacteria. Surprisingly, no asso-
ciation was identified between systemic IFN-γ production and 
DTH responses. Over 15 different cytokines, however, have been 
identified at the local site of tissue inflammation (62). In humans, 
it is known that TNF-α is more effective in inducing a local DTH 
response (62, 63). As a number of cytokines are involved in the 
DTH reaction, not just IFN-γ, it may explain the lack of associa-
tion between IFN-γ production and DTH responses.
cOnclUsiOn
We can conclude from this study that administration of PPD as 
part of the bTB test is associated with an increase in MAP anti-
body response. Associations were also identified between skin 
DTH responses to the bTB test and post-bTB test MAP antibody 
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response. Additionally, IFN-γ production was significantly 
increased at the post-bTB time point. The immune response 
identified post-bTB test administration may indicate a role for 
TB testing in controlling JD.
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